These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9309697)

  • 41. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
    Veitch K; Hue L
    Mol Pharmacol; 1994 Jan; 45(1):158-63. PubMed ID: 8302275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells.
    González-Aragón D; Ariza J; Villalba JM
    Biochem Pharmacol; 2007 Feb; 73(3):427-39. PubMed ID: 17123468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G
    Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
    Robertson GS; Matsumura H; Fibiger HC
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1058-66. PubMed ID: 7965768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I.
    Gassner B; Wüthrich A; Scholtysik G; Solioz M
    J Pharmacol Exp Ther; 1997 May; 281(2):855-60. PubMed ID: 9152394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroleptic medications inhibit complex I of the electron transport chain.
    Jackson-Lewis V; Przedborski S
    Ann Neurol; 1994 Feb; 35(2):244-5. PubMed ID: 7906502
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe extrapyramidal symptoms with fluvoxamine despite neuroleptics withdrawal.
    Thomas P; Roche J; Maron M; Cotencin O; Vaiva G; Goudemand M
    Eur Psychiatry; 1996; 11(5):273. PubMed ID: 19698466
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytostatic effect of neuroleptics.
    Neumann NU
    Acta Psychiatr Scand; 1988 Jul; 78(1):109. PubMed ID: 2902737
    [No Abstract]   [Full Text] [Related]  

  • 51. [V.P. Volkov. 'The cardiotoxicity of neuroleptics'. Tver: Triada; 2018:622].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):173-174. PubMed ID: 31317907
    [No Abstract]   [Full Text] [Related]  

  • 52. Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays.
    Rosell-Hidalgo A; Eakins J; Walker P; Moore AL; Ghafourian T
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Dosage of Antipsychotic Drug Aripiprazole Induces Persistent Mitochondrial Hyperpolarisation, Moderate Oxidative Stress in Liver Cells, and Haemolysis.
    Pirc Marolt T; Kramar B; Vovk A; Podgornik H; Šuput D; Milisav I
    Antioxidants (Basel); 2023 Oct; 12(11):. PubMed ID: 38001783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.
    De Simone G; Mazza B; Vellucci L; Barone A; Ciccarelli M; de Bartolomeis A
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.
    Roberts RC
    Mitochondrion; 2021 Jan; 56():91-101. PubMed ID: 33221354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Tardive Syndrome: Medications and Surgical Treatments.
    Factor SA
    Neurotherapeutics; 2020 Oct; 17(4):1694-1712. PubMed ID: 32720245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro effects of antipsychotics on mitochondrial respiration.
    Cikánková T; Fišar Z; Bakhouche Y; Ľupták M; Hroudová J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1209-1223. PubMed ID: 31104106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmortem studies on mitochondria in schizophrenia.
    Roberts RC
    Schizophr Res; 2017 Sep; 187():17-25. PubMed ID: 28189530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.
    Bergman O; Ben-Shachar D
    Can J Psychiatry; 2016 Aug; 61(8):457-69. PubMed ID: 27412728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-Induced Mitochondrial Toxicity.
    Hargreaves IP; Al Shahrani M; Wainwright L; Heales SJ
    Drug Saf; 2016 Jul; 39(7):661-74. PubMed ID: 26992920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.